Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HAVN Life Sciences Inc C.HAVN

Alternate Symbol(s):  HAVLF

HAVN Life Sciences Inc. is a Canada-based biotechnology company. The Company is engaged in the scientific research and development of psychopharmacological and natural health care products. It is focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing mental health treatments to support brain health and enhance the capabilities of the mind. The Company has two business divisions: HAVN Labs and HAVN Retail. The HAVN Labs division is engaged in the development of research protocols to cover the production of Psilocybe spp. Through its research division, HAVN Labs, it has developed an end-to-end supply chain of GMP naturally derived psychedelic compounds for research. The HAVN Retail division formulates and sells natural health products (NHPs) using compounds. It offers a full range of mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.


CSE:HAVN - Post by User

Post by Idvhmz123on Mar 19, 2021 8:12am
131 Views
Post# 32836191

HAVN News Release

HAVN News Release ORIGINAL: Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies 2021-03-19 08:00 ET - News Release CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET VANCOUVER, BC / ACCESSWIRE / March 19, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural healthcare products, announced today that it will be presenting virtually at the upcoming Zooming with LD event on Wednesday, March 24th 2020 at 8:00 AM PT/11:00 AM ET. Tim Moore, Chief Executive Officer of Havn Life, will give a 1-hour presentation to this audience of investors and media. Afterwards, Moore will be available for 1:1 meetings with attendees, offering an exclusive opportunity to ask questions and discuss Havn Life's business with the CEO. Founded in 2006, LD Micro is a leading, independent resource for the microcap world, curating events like Zooming With LD to connect the investment community with business leaders in the microcap space. WHO: Tim Moore, Havn Life Sciences CEO WHEN: Wednesday, March 24th 2020 at 8:00 AM PT/11:00 AM ET WHERE: Investors and other individuals may access the virtual presentation by registering here: https://us02web.zoom.us/webinar/register/WN_WwKAg8NzRPqULf2w-UZqog Chris Lahiji, Founder of LD Micro and host of Zooming With LD, noted "Psychedelic medicine has the potential to be a game-changer for millions of people around the world. At LD Micro, we are always eager to give a platform to unique, forward-thinking companies. Havn Life is bringing a truly new vision to biotech and natural healthcare products." On Behalf of The Board of Directors
<< Previous
Bullboard Posts
Next >>